International Myositis Society - Newsletter 2/22

Logo-CER (1)

Upcoming papers on Myositis in press at our home journal "Clinical and Experimental Rheumatology - CER"

  1. The effect of COVID-19 pandemic on idiopathic inflammatory myositis patients: a single centre experiences
    T. Béldi, A. Vincze, B. Miltényi-Szabo, Z. Varga, K. Szabo, Z. Griger, M. Nagy-Vincze
  2. Use of JAK inhibitors in dermatomyositis: a systematic literature review
    J.J. Paik, G. Lubin, A. Gromatzky, P.N. Mudd, M.P. Ponda, L. Christopher-Stine
  3. Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
    P.A. Olivo Pallo, S.K. Shinjo
These myositis-related articles will appear at CER and can be found there in the press section.
The Global Conference on Myositis starts next week!
The 4th GCOM 2022 will be held in Prague, Czech Republic on 6 – 9 June 2022 at the O2 Universum multifunctional centre. The conference will be organized as a hybrid meeting, i.e. with in-person attendance as well as with virtual participation using simultaneous online streaming. All information at the GCOM Website

iMyoS - Meeting at the GCOM

The International Myositis Society - iMyoS - will have a meeting for all iMyoS members that participate at the GCOM in Prague. It will take place on Wednesday the 8th of June 2022 from 4:45 - 5:45 CET. Remote access is also possible for members that have registered for GCOM.
Email Marketing Powered by MailPoet